SBW Life Sciences Co.,Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
For the six months, sales was KRW 1,415.94 million compared to KRW 0.00001 million a year ago. Net income was KRW 233.78 million compared to net loss of KRW 8,521.93 million a year ago. Basic earnings per share from continuing operations was KRW 1 compared to basic loss per share from continuing operations of KRW 49 a year ago. Diluted earnings per share from continuing operations was KRW 1 compared to diluted loss per share from continuing operations of KRW 49 a year ago. Basic earnings per share was KRW 1 compared to basic loss per share of KRW 49 a year ago.